In 313 infants with moderate or severe hypoxic-ischaemic encephalopathy receiving hypothermia, erythropoietin vs placebo did not reduce death or moderate/severe disability at 2 years (34.1% vs 28.7%; RR 1.19, 95% CI 0.84-1.68); no safety concerns.
RCTn = 313
Liley et al. Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial